Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)

B Lennox, G Tomei, S-A Vincent, K Yeeles, R Pollard, EC Palmer-Cooper, P Jones, M Zandi, A Coles.

J Neurol Neurosurg Psychiatry Published Online First: 11 June 2018. doi: 10.1136/jnnp-2018-318124

 

Psychosis: an autoimmune disease?

A Al-Diwani, T Pollak, S Irani, B Lennox

Immunology, 2017 (epub ahead of print) DOI: 10.1111/imm.12795

 

Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study

B Lennox, EC Palmer-Cooper, T Pollak, J Hainsworth, J Marks, L Jacobson, B Lang, ...

The Lancet Psychiatry 4 (1), 2016

 

The prevalence of antibodies against neuronal cell surface targets in acute first episode psychosis

EC Palmer, T Pollak, J Marks, JC Hainsworth, L Jacobsen, PB Jones, ...

SCHIZOPHRENIA BULLETIN 41, S150-S150, 2015

 

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission

L Scoriels, RM Salek, E Goodby, D Grainger, AM Dean, JA West, JL Griffin, ...

Translational psychiatry 5 (3), 2015

 

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

GM Khandaker, L Cousins, J Deakin, BR Lennox, R Yolken, PB Jones

The Lancet Psychiatry 2 (3), 258-270, 2015

 

N-methyl D-Aspartate receptor autoantibodies in psychiatric illness

MS Zandi, B Lennox, A Vincent

Biological Psychiatry, 2015

 

The Oxford Experience: Clinical Features And Outcomes of 25 NMDAR-Ab Positive Patients Including Those With Atypical Presentations (P5. 189)

K Morris, C Buckley, B Lennox, Y Hacohen, E Coutinho, A Vincent

Neurology 82 (10 Supplement), P5. 189-P5. 189, 2014

 

Autoimmune encephalitis: a potentially treatable cause of mental disorder

H Rickards, S Jacob, B Lennox, T Nicholson

Advances in psychiatric treatment 20 (2), 92-100, 2014

 

Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A description of a treated case series

MS Zandi, JB Deakin, K Morris, C Buckley, L Jacobson, L Scoriels, ...

Schizophrenia Research, 2014

 

Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes

MS Zandi, RW Paterson, MA Ellul, L Jacobson, A Al-Diwani, JL Jones, ...

J Neurology, Neurosurgery & Psychiatry, 2014

 

Young people's views of UK mental health services

J Plaistow, K Masson, D Koch, J Wilson, RM Stark, PB Jones, BR Lennox

Early intervention in psychiatry, 8 (1), 12-23, 2014

 

NMDA receptor antibodies in first episode psychosis: prevalence and clinical phenotype

B Lennox, MS Zandi, JB Deakin, A Coles, L Scoriels, P Jones, E Coutinho, ...

Schizophrenia Research, S35, 2014

 

Movement disorders and psychiatry. Five new things.

G Cummins, M Zandi, RA Barker

Neurology Clinical Practice, 2014

 

Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia

E Needham, MS Zandi

Journal of Neurology, 2014

 

Long term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis

JWL Brown, PJ Martin, JW Thorpe, AW Michell, AJ Coles, AL Cox, ...

Journal of Neuroimmunology, 2014

 

Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis

J Deakin, BR Lennox, MS Zandi

Biological psychiatry 75 (4), 284-291, 2014

 

Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis

A Fornito, BJ Harrison, E Goodby, A Dean, C Ooi, PJ Nathan, BR Lennox, ...

JAMA psychiatry 70 (11), 1143-1151, 2013

 

Psychotic symptoms in young people warrant urgent referral.

J Deakin, B Lennox

The Practitioner 257 (1759), 25-8, 3, 2013

 

Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity

MS Zandi

Brain 136 (10), 2933-2935, 2013

 

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre

RW Paterson, MS Zandi, R Armstrong, A Vincent, JM Schott

Journal of Neurology, Neurosurgery & Psychiatry, 2013

 

Antibody-mediated encephalitis: a treatable cause of schizophrenia

BR Lennox, AJ Coles, A Vincent

The British Journal of Psychiatry, 200 (2) 92-94, 2012

 

TWO INTERESTING CASES OF NMDAR ENCEPHALITIS AND A TYPICAL BUT SERONEGATIVE CASE WITH OVARIAN TERATOMA

M Ellul, S Sawcer, AJ Coles, MS Zandi

Journal of Neurology, Neurosurgery & Psychiatry 83 (Suppl 2), A7-A7, 2012

 

Disease-relevant autoantibodies in first episode schizophrenia

MS Zandi, SR Irani, B Lang, P Waters, PB Jones, P McKenna, AJ Coles, ...

Journal of neurology 258 (4), 686-688 2011

 

POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: a retrospective study of the Cambridge experience

M Zandi, F Catapano, S Burns, FC Hall, KGC Smith, DRW Jayne, ...

Journal of Neurology, Neurosurgery & Psychiatry 81 (11), e54-e54, 2010

 

Treatment of neuro-Behcet's disease with infliximab. An International Multicentre Case-Series of 18 patients

A Al-araji, ASS Saip, C Constantinescu, G Akman-demir, T Arayssi, ...

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 28 (4), S119-S119, 2010

 

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ...

Brain 133 (6), 1655-1667, 2010

 

Advances and Challenges in Neuropsychiatric Systemic Lupus Erythematosus

M Zandi

Advances in Clinical Neuroscience and Rehabilitation 10, 8-13, 2010

 

Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma

MS Zandi, SR Irani, G Follows, AM Moody, P Molyneux, A Vincent

Neurology 73 (23), 2039-2040, 2009